Actively Recruiting

Phase Not Applicable
All Genders
NCT06416345

Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

Led by Amsterdam UMC, location VUmc · Updated on 2026-03-16

84

Participants Needed

2

Research Sites

118 weeks

Total Duration

On this page

Sponsors

A

Amsterdam UMC, location VUmc

Lead Sponsor

R

Radboud University Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

The majority of people with Parkinson's disease incur Freezing of Gait (FoG), which is not addressed adequately by medication. Cueing is a proven strategy to overcome FoG. The Cue2Walk is a device with automated detection of FoG and provision of rhythmic cues. In this study, the (cost-)effectiveness of the Cue2Walk device as compared to usual care is investigated.

CONDITIONS

Official Title

Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Parkinson's disease according to UK Brain bank criteria
  • Daily Freezing of Gait
  • Hoehn-Yahr stage 2-4
  • Stable medication regime and/or DBS settings as determined by the treating neurologist
  • Ability to walk 5 minutes while unassisted by another person
Not Eligible

You will not qualify if you...

  • Participation in another clinical study
  • Use of a personal cueing device at home
  • Previous use of the Cue2Walk medical device
  • Presence of co-morbidities that would hamper participation
  • Cognitive impairment preventing understanding of therapeutic instructions (Montreal Cognitive Assessment (MoCA) Score <16)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Radboudumc

Nijmegen, Gelderland, Netherlands, 6525 GA

Not Yet Recruiting

2

Amsterdam UMC, location VUmc

Amsterdam, North Holland, Netherlands, 1081HZ

Actively Recruiting

Loading map...

Research Team

E

Erwin EH van Wegen, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here